MA HUANG EXEMPTION FROM DEA EPHEDRINE REGULATION
This article was originally published in The Tan Sheet
Executive Summary
MA HUANG EXEMPTION FROM DEA EPHEDRINE REGULATION based on the herbal's status as a dietary supplement has been requested by the New York law firm Bass & Ullman on behalf of BDI Pharmaceuticals and Valley Run Pharmaceuticals. In a Dec. 9 letter to the Drug Enforcement Administration, Bass & Ullman argued that the agency's "authority is limited to drug products containing ephedrine and does not extend to dietary supplements of Ma Huang because such products are not 'drugs' under the" FD&C Act.